\-\ Texto\\:\\ \ \(0\)\
\-\ unknown\ \(157\)\
\-\ unknown\ \(157\)\
\-\ sonographic\\ evaluation\\ of\\ the\\ kidneys\\ demonstrate\\ increased\\ echogenicity\\ of\\ the\\ medullary\\ pyramids\\.\ \(0\)\
\-\ medullary\\ nephrocalcinosis\ \(9\)\
\-\ hyperparathyroidism\\ \ \(11\)\
\-\ medullary\\ sponge\\ kidney\\ \ \(1\)\
\-\ renal\\ tubular\\ acidosis\\ \ \(2\)\
\-\ milk\\-alkali\\ syndrome\\ \ \(0\)\
\-\ hyperthyroidism\\ \ \(14\)\
\-\ hypothyroidism\\ \ \(13\)\
\-\ sarcoidosis\\ \ \(52\)\
\-\ furosemide\\ therapy\\ \ \(0\)\
\-\ vitamin\\ d\\ therapy\\ \ \(0\)\
\-\ rickets\ \(46\)\
\-\ 27\\ y\\/o\\ female\\ with\\ history\\ of\\ \\"severe\\ nephrolithiasis\\.\\"\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\-milk\\-alkali\\:\\ 0\\.19164170486883692\ \(0\)\
\-\ \\-furosemide\\:\\ 0\\.19164170486883692\ \(0\)\
\-\ \\-vitamin\\:\\ 0\\.19164170486883692\ \(0\)\
\-\ \\-rickets\\:\\ 0\\.19164170486883692\ \(0\)\
\-\ medullary\\:\\ 0\\.1785212270719202\ \(0\)\
\-\ \\-hyperthyroidism\\:\\ 0\\.17657328790014246\ \(0\)\
\-\ \\-sarcoidosis\\:\\ 0\\.17657328790014246\ \(0\)\
\-\ \\-hyperparathyroidism\\:\\ 0\\.16775882902822584\ \(0\)\
\-\ \\-hypothyroidism\\:\\ 0\\.16775882902822584\ \(0\)\
\-\ \\-medullary\\:\\ 0\\.15665392416374777\ \(0\)\
\-\ unknown\\:\\ 0\\.14499476089671767\ \(0\)\
\-\ \\-renal\\:\\ 0\\.14387595318761473\ \(0\)\
\-\ pyramids\\:\\ 0\\.13427089335546172\ \(0\)\
\-\ nephrocalcinosis\\:\\ 0\\.1300501104328322\ \(0\)\
\-\ sponge\\:\\ 0\\.1300501104328322\ \(0\)\
\-\ acidosis\\:\\ 0\\.11999307734700368\ \(0\)\
\-\ nephrolithiasis\\:\\ 0\\.10937671282713558\ \(0\)\
\-\ echogenicity\\:\\ 0\\.09991327649544329\ \(0\)\
\-\ therapy\\:\\ 0\\.09933220853220057\ \(0\)\
\-\ d\\:\\ 0\\.09264438113839038\ \(0\)\
\-\ sonographic\\:\\ 0\\.09005846933705634\ \(0\)\
\-\ tubular\\:\\ 0\\.08650514167423957\ \(0\)\
\-\ 27\\:\\ 0\\.08616278608797567\ \(0\)\
\-\ kidneys\\:\\ 0\\.0854938369865245\ \(0\)\
\-\ kidney\\:\\ 0\\.06544311858804369\ \(0\)\
\-\ severe\\:\\ 0\\.05715890869708705\ \(0\)\
\-\ evaluation\\:\\ 0\\.05396171295275669\ \(0\)\
\-\ syndrome\\:\\ 0\\.05312840384205742\ \(0\)\
\-\ y\\/o\\:\\ 0\\.05144845716999218\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.04565510951373515\ \(0\)\
\-\ increased\\:\\ 0\\.045445321343470776\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.044777163086570496\ \(0\)\
\-\ demonstrate\\:\\ 0\\.042748959594196535\ \(0\)\
\-\ female\\:\\ 0\\.038190440683648554\ \(0\)\
\-\ history\\:\\ 0\\.02565683777624094\ \(0\)\
\-\ of\\:\\ 0\\.007598073965086201\ \(0\)\
\-\ the\\:\\ 0\\.006010838465375035\ \(0\)\
\-\ with\\:\\ 0\\.0025435690454323856\ \(0\)\
\-\ \\.\\:\\ 0\\.0015434580911889684\ \(0\)\
